QA: RAPT Therapeutics Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001673772_2022_RAPT_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001673772, RAPT Therapeutics Inc

  xvar xval
0 AssetsCurrent 192,973,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,741,000
3 remainder_Assets 2,922,000
4 LiabilitiesCurrent 9,595,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 2,661,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 16,037,000
9 ResearchAndDevelopmentExpense 56,985,000
10 remainder_Expenses 0
11 remainder_Revenues 3,813,000
12 remainder_NetIncome 5,000
13 remainder_ComprehensiveNetIncome -29,000
  yvar yval
0 Assets 198,636,000
1 Liabilities 12,256,000
2 Expenses 73,022,000
3 Revenues 3,813,000
4 StockholdersEquity 186,380,000
5 NetIncome -69,204,000
6 ComprehensiveNetIncome -69,218,500
7 BaseVar 143,880,500
8 EconomicCapitalRatiobeforeLimitedLiability 3.20
9 EconomicCapitalRatio 3.82

Edgar->Model Mapping

Feature Distribution

Change over Time